Status:
RECRUITING
Investigating Composite Biomarkers for Pain Catastrophizing
Lead Sponsor:
Aalborg University
Conditions:
Pain, Acute
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Pain is a complex, multidimensional, and subjective experience; and although, investigators use a single word "pain", to describe our perception, multiple mechanisms contribute to the generation and m...
Eligibility Criteria
Inclusion
- Healthy men and women in the age 18-80 years
- Speak and understand English
Exclusion
- Acute and chronic pain
- Pregnancy or breastfeeding
- Drug addiction defined as the use of cannabis, opioids or other drugs
- Present or previous history of neurological, dermatological, immunological, musculoskeletal, cardiac disorder or mental illnesses that may affect the results (e.g. Neuropathy, muscular pain in the upper extremities, etc.)
- Focal and generalized seizure
- Surgery or any other therapy for epilepsy
- Present or previous AEDs (anti-epileptic drugs) administration
- Present or previous use of epileptic devices (\<1 year prior the enrolment)
- Lack of ability to cooperate
- Current use of medications that may affect the trial, such as antipsychotics and pain killers as well as systemic or topical steroids and anti-inflammatory drugs.
- Skin diseases
- Consumption of alcohol or painkillers 24 hours before the study days and between these
- Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical trials)
Key Trial Info
Start Date :
October 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04787198
Start Date
October 15 2022
End Date
December 31 2025
Last Update
February 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University
Aalborg, Denmark, 9220